Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10579103 | 0.90 | LMNA (0.43) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL9683141 | 0.89 | DGKA (0.54) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL11815183 | 0.87 | DGKA (0.58) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL8918163 | 0.87 | — | — | |
| SCHEMBL8918169 | 0.87 | — | — | |
| SCHEMBL5498642 | 0.85 | — | — | |
| SCHEMBL28089557 | 0.85 | — | — | |
| SCHEMBL8724105 | 0.85 | ADRA2A (0.43) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL11821099 | 0.83 | TDP1 (0.39) | ADRA2AADRA1AMAPTBLMDGKA | |
| SCHEMBL27928370 | 0.83 | ADRA2A (0.41) | ADRA2AADRA1AMAPTBLMDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | claimed |
| US-11631897-B2 | Ionic liquid additive for lithium-ion battery | HIGH TECH BATTERY INC. (TW) | 2023-04-18 | — | — | US | disclosed |
| US-11626620-B2 | Ionic liquid additive for lithium-ion battery | HIGH TECH BATTERY INC. (TW) | 2023-04-11 | — | — | US | disclosed |
| US-20220238918-A1 | IONIC LIQUID ADDITIVE FOR LITHIUM-ION BATTERY | HIGH TECH BATTERY INC. (TW) | 2022-07-28 | — | — | US | disclosed |
| EP-4033581-A1 | IONIC LIQUIDS FOR USE AS ADDITIVE FOR A LITHIUM-ION BATTERY | High Tech Battery Inc. (TW) | 2022-07-27 | — | — | EP | disclosed |
| US-20220231335-A1 | IONIC LIQUID ADDITIVE FOR LITHIUM-ION BATTERY | HIGH TECH BATTERY INC. (TW) | 2022-07-21 | — | — | US | disclosed |
| EP-3954722-A1 | PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM | Evonik Operations GmbH (DE) | 2022-02-16 | — | — | EP | disclosed |
| US-20220033603-A1 | PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM | EVONIK OPERATIONS GMBH (DE) | 2022-02-03 | — | — | US | disclosed |
| WO-2014024207-A1 | PROCESS FOR PREPARATION OF SUCCINYLCHOLINE CHLORIDE | NEON LABORATORIES LTD. (IN) | 2014-02-13 | — | — | WO | disclosed |
| CN-1139432-A | Prodrugs of inhibitor of HIV protease | MERCK & CO INC (US) | 1997-01-01 | — | — | CN | disclosed |
| US-5206420-A | Reacting dialkyl succinates with excess dimethylaminoethanol an the presence of an alkali metal alcoholate or alkali metal amide catalyst; reacting the product with methyl halides | HAFSLUND NYCOMED PHARMA AKTIENGESELLSCHAFT (AT) | 1993-04-27 | — | — | US | disclosed |
| CN-1069485-A | Process for preparation of succinylcholine halides | HAFSLUND NYCOMED PHARMA (AT) | 1993-03-03 | — | — | CN | disclosed |
| US-4859229-A | HERBICIDES | HOFFMANN-LA ROCHE INC. (US) | 1989-08-22 | — | — | US | disclosed |
| US-4104233-A | VINYL HALIDE POLYMERS, SMOKE AND FIRE RETARDANTS | MONSANTO COMPANY (US) | 1978-08-01 | — | — | US | disclosed |
| US-4059610-A | Process for preparing isocyanic acid derivatives | KAO SOAP CO., LTD. (JA) | 1977-11-22 | — | — | US | disclosed |
| US-3976627-A | Vulcanizable compositions of carboxyl-containing polymers | THE B.F. GOODRICH COMPANY (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220033603-A1 | PROCESS AND COMPOSITION FOR THE PRODUCTION OF FLEXIBLE POLYURETHANE FOAM | PUF60, FUS, PCBP1 | ADRA2A 4443/4885ADRA1A 4605/4885MAPT 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.